Regulus pairs with Sanofi in $750M microRNA pact

Regulus Pharmaceuticals is partnering up with Sanofi-Aventis in a $750 million microRNA discovery and development deal, garnering $25 million of that upfront with the promise of a $10 million equity payment. Launched with the backing of Alnylam and Isis, Regulus also obtained an option on a broader R&D alliance that would be worth $50 million. Billed as the largest microRNA partnership yet formed, Sanofi and Regulus will collaborate on four microRNA targets, focusing on...